🧠 Mild Cognitive Impairment: Don’t Wait to Take Action 🧠 Hope is real—and timing matters.

 

🧠 Mild Cognitive Impairment: Don’t Wait to Take Action 🧠

Hope is real—and timing matters.

If you’ve noticed early signs of forgetfulness, difficulty concentrating, or subtle changes in cognitive function—whether in yourself or someone you love—this post is for you.

📸 In the image above, you’ll see Kisunla (donanemab), one of the newest FDA-approved infusion therapies designed to help slow the progression of Alzheimer’s disease when caught early. It's a sign of progress—and hope—for patients facing mild cognitive impairment (MCI).

Another breakthrough option is Leqembi (lecanemab). Like Kisunla, Leqembi is FDA-approved, covered by Medicare and most commercial insurance plans, and represents a powerful advancement in how we approach early-stage cognitive decline.

💡 Why does early action matter?
These treatments are designed to have the most impact before cognitive decline becomes severe. When started early, they may help slow progression and preserve independence longer. But once symptoms advance, the window of opportunity to benefit from these therapies can narrow.

🩺 As with any medical treatment, there are potential side effects and risks that should be carefully discussed with a neurologist. But doing nothing and simply “waiting to see” may limit your options later on.

🏥 At Noble Infusion, we provide a calm, comfortable environment to receive IV therapies like Kisunla and Leqembi, working closely with referring specialists to ensure patients receive expert care every step of the way. We serve patients from Ormond Beach, Port Orange, and throughout the Daytona Beach area.

✨ Take the first step—don’t wait.

• Talk to your doctor about any signs of memory or cognitive change.

• Ask if a medication like Kisunla or Leqembi might be right for you or a loved one.

• Reach out to us at Noble Infusion if you have questions or need support understanding the process.

Early action isn't just proactive—it’s powerful.